This inventor holds 1 USPTO granted patent. Top assignees: Federalnoe Gosudarstvennoe Unitarnoe Predpriyatie “Gosudarstvenny Nauchny Tsentr Nauchno-Issledovatelsky Institut Organicheskikh Poluproduktov I Krasitelei” (Fgup “Gntts Niopik”), Gosudarstevennoe Obrazovatelnoe Uchrezhdenie Vysshego Professionalnogo Obrazovaniya Moskovskaya Meditsinskaya Akademiya Im. I.m. Sechenova Rf (Gouvpo Mma Im. I.m. Sechenova Mz Rf). Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2 
1 out of 1 Years Active: 2007
Title: Eduard Izrailevich Galperin: Innovator in Liver Tumor Therapy
Introduction
Eduard Izrailevich Galperin is a notable inventor based in Moscow, Russia, known for his innovative contributions to medical therapies. With a focus on liver oncology, Galperin's work has led to advancements in therapeutic methods for liver tumors, showcasing his dedication to improving patient outcomes.
Latest Patents
Galperin holds a patent for a novel method for the therapy of liver tumors. This method, which involves the regional administration of preparations into a branch of the portal vein while occluding afferent and efferent lobe vessels for 5–15 minutes, aims at enhancing the effectiveness of treatment. It specifies the use of Teraphtalum during catalytic therapy along with the administration of ascorbic acid post-occlusion. For photodynamic therapy, photosens is recommended, with tumor irradiation occurring 10–35 minutes later. This approach allows for significant accumulation of the preparations in the tumor carrier lobe of the liver while minimizing systemic exposure, thus reducing overall toxicity.
Career Highlights
Throughout his career, Galperin has been associated with several prominent organizations. He worked at Federal State Unitary Enterprise Scientific Research Institute of Organic Semi-Finished Products and Dyes (FGUP GNTTS "NIOPIK") and at the Sechenov First Moscow State Medical University (GOUVPO MMA Im. I.M. Sechenova MZ RF). His work in these institutions has allowed him to advance his research and invention processes significantly.
Collaborations
Galperin has collaborated with notable individuals in his field, including Georgy Nikolaevich Vorozhtsov and Roman Sergeevich Goloschapov. These partnerships have fostered a creative environment that has undoubtedly contributed to the innovation of therapeutic methodologies in liver cancer treatment.
Conclusion
Eduard Izrailevich Galperin's contributions to the field of liver tumor therapy are remarkable. With his patented method, he has paved the way for more effective and less toxic treatment options for patients. His collaborations and extensive work experience further enhance his legacy as an influential inventor in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile